Basic Information
| LncRNA/CircRNA Name | snaR |
| Synonyms | SNAR-A1, SNAR-A53113498 |
| Region | GRCh19:47918429-47918550 |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | qPCR, Western blot |
| Sample | blood, cell lines(UWB1.289, SV40) |
| Expression Pattern | up-regulated |
| Function Description | It was observed that plasma levels of lncRNA snaR and GAB2 were significantly higher in OC patients than those in healthy controls. LncRNA snaR overexpression promoted cancer cell proliferation and upregulated GAB2 expression. |
| Pubmed ID | 30093110 |
| Year | 2018 |
| Title | LncRNA snaR Upregulates GRB2-associated Binding Protein 2 and Promotes Proliferation of Ovarian Carcinoma Cells. |
External Links
| Links for snaR | GenBank HGNC NONCODE |
| Links for ovarian cancer | OMIM COSMIC |